GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (FRA:QL1A) » Definitions » Loans Receivable

QuidelOrtho (FRA:QL1A) Loans Receivable : €0 Mil (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is QuidelOrtho Loans Receivable?

QuidelOrtho's Loans Receivable for the quarter that ended in Mar. 2024 was €0 Mil.


QuidelOrtho Loans Receivable Historical Data

The historical data trend for QuidelOrtho's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Loans Receivable Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

QuidelOrtho Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

QuidelOrtho Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


QuidelOrtho Loans Receivable Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (FRA:QL1A) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

QuidelOrtho (FRA:QL1A) Headlines

No Headlines